These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29796808)

  • 21. Morphological study of the efficiency of isoniazid and dialdehyde dextran composition in the treatment of mice with BCG granulomatosis.
    Shkurupiy VA; Kozyaev MA; Potapova OV
    Bull Exp Biol Med; 2008 Dec; 146(6):853-6. PubMed ID: 19513404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inoculation of bacille calmette guerin combined with intraperitoneal adenosine injection enhances antibacterial effect of macrophage against Mycobacterium tuberculosis in mice].
    Pan JH; Lou WL; Zhou HQ; Shen HY; Chen LJ
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):932-5. PubMed ID: 15733366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the Efficiency of Different Antituberculous Drugs and Approaches to Treat BCG-Induced Granulomatosis in Mice and Abundance and Localization of Mycobacterium tuberculosis in the Liver.
    Sinyavskaya AM; Shkurupy VA; Troitskii AV; Kovner AM
    Bull Exp Biol Med; 2020 Dec; 170(2):233-235. PubMed ID: 33269454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung.
    Okamoto Yoshida Y; Umemura M; Yahagi A; O'Brien RL; Ikuta K; Kishihara K; Hara H; Nakae S; Iwakura Y; Matsuzaki G
    J Immunol; 2010 Apr; 184(8):4414-22. PubMed ID: 20212094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic complications of MER immunotherapy of cancer: pulmonary granulomatosis and rash.
    Voith MA; Lichtenfeld KM; Schimpff SC; Wiernik PH
    Cancer; 1979 Feb; 43(2):500-4. PubMed ID: 421177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
    Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
    J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of granulomas in interferon-gamma gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis.
    Sugawara I; Yamada H; Kazumi Y; Doi N; Otomo K; Aoki T; Mizuno S; Udagawa T; Tagawa Y; Iwakura Y
    J Med Microbiol; 1998 Oct; 47(10):871-7. PubMed ID: 9788810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirements for CD4(+) T cell levels in acute Mycobacterium bovis strain bacille Calmette Guerin (BCG)-induced granulomas differ for optimal mycobacterial control versus granuloma formation.
    Hogan LH; Heninger E; Elsner RA; Vonderheid HA; Hulseberg P; Co D; Sandor M
    Int Immunol; 2007 May; 19(5):627-33. PubMed ID: 17446212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.
    Tree JA; Williams A; Clark S; Hall G; Marsh PD; Ivanyi J
    Clin Exp Immunol; 2004 Dec; 138(3):405-9. PubMed ID: 15544615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granuloma formation in patients receiving BCG immunotherapy.
    Whittaker JA; Bentley DP; Melville-Jones GR; Slater AJ
    J Clin Pathol; 1976 Aug; 29(8):693-7. PubMed ID: 1066353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of pulmonary foreign body granulomatous inflammation in mice by lipopolysaccharide: involvement of macrophage activation and tumor necrosis factor-alpha.
    Kasama T; Kobayashi K; Yamagata N; Iwabuchi H; Matsuda T; Nakatani K; Kasahara K; Takahashi T
    Int Arch Allergy Immunol; 1992; 97(2):130-8. PubMed ID: 1316316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.
    Roch F; Bach MA
    Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppression by peritoneal BCG-induced granulomas in mice.
    Alessi AC; Ribeiro-dos-Santos R; Silva JS
    Braz J Med Biol Res; 1990; 23(3-4):263-74. PubMed ID: 2128819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic granulomas induced by Schistosoma mansoni in mice deficient for connexin 43 present lower cell proliferation and higher collagen content.
    Oloris SC; Mesnil M; Reis VN; Sakai M; Matsuzaki P; Fonseca Ede S; da Silva TC; Avanzo JL; Sinhorini IL; Guerra JL; Costa-Pinto FA; Maiorka PC; Dagli ML
    Life Sci; 2007 Mar; 80(13):1228-35. PubMed ID: 17289089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental cytomorphological studies of the reaction of mononuclear phagocyte system in granulomatosis of mixed (silicotic and tuberculous) etiology.
    Shkurupy VA; Nadeev AP; Karpov MA; Bugrimova YS
    Bull Exp Biol Med; 2010 Oct; 149(4):462-5. PubMed ID: 21234444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection.
    Emile JF; Patey N; Altare F; Lamhamedi S; Jouanguy E; Boman F; Quillard J; Lecomte-Houcke M; Verola O; Mousnier JF; Dijoud F; Blanche S; Fischer A; Brousse N; Casanova JL
    J Pathol; 1997 Jan; 181(1):25-30. PubMed ID: 9071999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of mycobacterial granulomas in guinea-pig lymph nodes.
    Narayanan RB; Badenoch-Jones P; Curtis J; Turk JL
    J Pathol; 1982 Nov; 138(3):219-33. PubMed ID: 6752360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCG granuloma appearing more than 50 years after vaccination.
    Seishima M; Fujisawa T; Yamanaka S; Ishii N; Mori S; Ohashi K; Suzutani T
    Arch Dermatol; 2006 Feb; 142(2):249-50. PubMed ID: 16490863
    [No Abstract]   [Full Text] [Related]  

  • 40. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI.
    Senaldi G; Yin S; Shaklee CL; Piguet PF; Mak TW; Ulich TR
    J Immunol; 1996 Dec; 157(11):5022-6. PubMed ID: 8943410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.